The hemostats market is expected to prosper due to factors such as the growing emphasis on blood loss management during surgeries, emphasis on improving the safety and usability of hemostats for end users, and technological advancements, which are expected to result in appreciable revenue growth in the hemostats market during the forecast period (2022–2027).
LAS VEGAS, Aug. 16, 2022 /PRNewswire/ -- DelveInsight's Hemostats Market Insights report provides the current and forecast market, forthcoming device innovation, individual leading companies' market shares, challenges, Hemostats market drivers, barriers, and trends, and key Hemostats companies in the market.
Key Takeaways from the Hemostats Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global hemostats market during the forecast period.
- Key hemostats companies such as Baxter International Inc., Johnson and Johnson, GELITA Medical, B. Braun Melsungen AG, Hemostasis LLC, Stryker Corporation, Pfizer, Mallinckrodt, CryoLife, Integra Life Sciences, Cura Medical, Meril Life Sciences, Beijing Datsing Bio-Tech, Zhonghui Shengxi, Curasan AG, Teflex Inc, Biotemed, BD, Biom'up, Foryou Medical, and several others are currently dominating hemostats market.
- In April 2022, Alcon, Ethicon (Johnson and Johnson) announced the launch of Enseal XI Straight Jaw Tissue sealer, which enables stronger tissue healing, also having easy access to the target tissue in multiple surgical procedures with greater efficiency.
- In July 2021, Medcura Inc. launched Rapid-Seal, which is an antibacterial hemostatic high-performance gel that assists in providing better wound treatment and fights infections with antibacterial capabilities.
- In February 2021, FDA approved the use of the EndoClot Polysaccharide Hemostatic System, manufactured by EndoClot Inc. This hemostatic system is said to control the bleeding rapidly and efficiently in case of gastrointestinal surgeries.
To read more about the latest highlights related to the hemostats market, get a snapshot of the key highlights entailed in the Global Hemostats Market Report
Hemostats are medical devices that contain hemostatic chemicals and are used when primary techniques of controlling bleeding, such as ligation or pressure, fail. These hemostats can be flowable, gelatins, thrombins, oxidized regenerated celluloses, and so forth.
Hemostats are essential during surgical procedures because they allow for superior blood loss management. The items can be used both intraoperatively and postoperatively. Hemostats are useful for oozing venous type bleeds, bare surface bleeding diffusion, bone bleeding, and needle-hole bleeding.
Hemostats Market Insights
North America is predicted to be the most profitable region in the global hemostats market. This can be attributed to the rising number of surgical procedures occurring in the North American region, which can be attributed to a growing patient population requiring surgical procedures, advanced healthcare infrastructure, a highly potent market in terms of product development and launches, and the local presence of key market players, among other factors in the region. Moreover, the increasing number of operations in the North American region is one of the major reasons driving the growth of the North American hemostats market.
In addition to the number of surgical procedures, product advancements, and recent product approvals, the hemostats market is predicted to rise. As a result, the presence of a large patient population base and end users, combined with manufacturers' increasing focus on launching new products and more products receiving commercial use approvals, is expected to boost the growth of the hemostats market in the North America region during the forecast period (2022-2027).
To know more about why North America is leading the market growth in the hemostats market, get a snapshot of the report Hemostats Market Outlook
Hemostats Market Dynamics
The increasing number of surgical procedures worldwide is one of the significant drivers of the hemostats market. Another important factor driving the growth of the hemostats market is the constant technological breakthroughs in hemostat development. For example, in February 2022, Dolphin Hemostats, a division of Futura SurgiCare Pvt. Ltd., introduced a variety of hemostatic products under the brand name Hemostax, an oxidized regenerated cellulose type hemostat. In a related development, Endoclot's EndoClot Polysaccharide Hemostatic System received FDA approval inFebruary 2021. In the case of gastrointestinal surgery, this hemostatic mechanism aids in the efficient and speedy stoppage of bleeding. Similarly, MedCura Inc. launched Rapid Seal in July 2021, a high-performance gel with antibacterial characteristics that improve wound therapy and fights infections. Such product development operations reflect an active research and development area, which results in the market introduction of improved products, which contributes to product uptake and, eventually, hemostats market growth.
However, a lack of qualified specialists for the efficient use of hemostats, as well as their expensive cost, may act as restraints on the hemostats market's growth.
Get a sneak peek of the hemostats market @ Hemostats Market Trends
Scope of the Hemostats Market Report
- Coverage: Global
- Study Period: 2019–2027
- Market Segmentation By Types of Hemostats: Thrombin-Based Hemostats, Oxidize Regenerated Cellulose-Based Hemostats, Gelatin Based-Hemostats, Collagen Based-Hemostats
- Market Segmentation By Application: General Surgery, Neurosurgery, Orthopedic Surgery, Reconstructive Surgery, Others
- Market Segmentation By Formulants: Matrix And Gel Hemostats, Sponge Hemostats, Powder Hemostats, Others
- Market Segmentation By End User: Hospitals, Clinics, Ambulatory Surgical Centres, Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Key Hemostats Companies: Baxter International Inc., Johnson and Johnson, GELITA Medical, B. Braun Melsungen AG, Hemostasis LLC, Stryker Corporation, Pfizer, Mallinckrodt, CryoLife, Integra Life Sciences, Cura Medical, Meril Life Sciences, Beijing Datsing Bio-Tech, Zhonghui Shengxi, Curasan AG, Teflex Inc, Biotemed, BD, Biom'up, Foryou Medical, among others
- Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
DelveInsight Analysis: The Hemostats market size is expected to grow at a CAGR of 5.72% to reach USD 5.07 billion by 2027.
Which MedTech key players in the hemostats market are set to emerge as the trendsetter explore @ Hemostats Companies
Table of Contents
Regulatory and Patent Analysis
Key Factors Analysis
Porter's Five Forces Analysis
COVID-19 Impact Analysis on Hemostats Market
Hemostats Market Layout
Global Company Share Analysis – Key 3-5 Companies
Company and Product Profiles
Interested in knowing how the hemostats devices market will grow by 2027? Click to get a snapshot of the Hemostats Market Analysis
Hemostasis and Tissue Sealing Agents Market
Hemostasis and Tissue Sealing Agents Market Insights, Competitive Landscape and Market Forecast - 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key hemostasis and tissue sealing agents companies including BD, Ethicon. Inc, Pfizer, Baxter, H.B. Fuller Company, among others.
Spine Augmentation Devices Market
Spine Augmentation Devices Market Insights, Competitive Landscape and Market Forecast - 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key spine augmentation devices companies, including Alphatec Holdings, Inc., B. Braun Melsungen AG, Exactech, Inc., Johnson & Johnson (DePuy Synthes), Globus Medical, Inc., among others.
Spinal Cord Stimulators Market
Spinal Cord Stimulators Market Insights, Competitive Landscape and Market Forecast - 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key spinal cord stimulators companies, including Boston, Scientific, and corporation, Medtronic plc, Nevro corp., St. Jude Medical, Greatbatch, and Stimwave, among others.
Spinal Cord Injury Market
Spinal Cord Injury Market Insights, Epidemiology and Market Forecast - 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key spinal cord injury companies, including Kringle Pharma, Eusol Biotech, Pharmicell, Pharmazz, AbbVie, among others.
Spinal Muscular Atrophy Market
Spinal Muscular Atrophy Market Insights, Epidemiology and Market Forecast - 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key spinal muscular atrophy companies, including Scholar Rock, Biogen, Astellas Pharma, Alcyone Therapeutics, AndroScience Corporation, among others.
Spinal Stenosis Devices Market
Spinal Stenosis Devices Market Insights, Competitive Landscape and Market Forecast - 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key spinal stenosis devices companies, including Spinal Simplicity LLC, Boston Scientific Corporation, Medtronic, Stryker, Surgalign, Zimmer Biomet, NuVasive Inc., among others.
Surgical Bleeding Pipeline
Surgical Bleeding Pipeline Insight and Competitive Landscape 2022 report delivers an in-depth understanding of pipeline devices, Product description, and key surgical bleeding companies, including Mallinckrodt, Syneos Health, Biom'Up France SAS, among others.
Uncontrolled Bleeding Pipeline
Uncontrolled Bleeding Pipeline Insight and Competitive Landscape 2022 report delivers an in-depth understanding of pipeline devices, Product description, and key uncontrolled bleeding companies, including BioMarin Pharmaceutical, Novo Nordisk, Sanofi, Pfizer, among others.
Other Trending Reports
Persistent Depressive Disorder Market | Gene Therapy for Ocular Rare Disease Market | Congestive Heart Failure Market | CRISPR Therapies Pipeline | Desmoplastic Small Round Cell Tumors Market | India Healthcare Outlook Report | Psychosis Market | Dental Lasers Market | Primary Immune Deficiency Market I Dyslipidemia Market | Lateral Epicondylitis Disease Market | Castration-Resistant Prostate Cancer Market | Metrorrhagia Market | Global Messenger RNA-based Vaccines and Therapeutics Market | Negative Pressure Wound Therapy Systems Market | US Healthcare Outlook Report | Mucinous Cystic Neoplasms Market | Hot Flashes Market | Varicose Veins - Market | Hemostats Market | Injectable Drug Delivery Devices Market | Breast Pumps Market | Physiotherapy Equipment Market | Trastuzumab Biosimilars Insight | Deep Brain Stimulation Devices Market | Retinoblastoma Market | Venous Stenosis Market | Tumor Ablation Market | Substance Abuse Market | Insulin Glargine Biosimilar Insight | Interspinous Spacers Market | Anti-hypertension Market
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
View original content:https://www.prnewswire.com/news-releases/the-global-hemostats-market-to-register-incremental-growth-at-a-cagr-of-5-72-by-2027--delveinsight-301606268.html
SOURCE DelveInsight Business Research, LLP